# A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma

> **NCT00223899** · PHASE1 · COMPLETED · sponsor: **Vical** · enrollment: 26 (actual)

## Conditions studied

- Metastatic Melanoma

## Interventions

- **GENETIC:** VCL-IM01 (encoding IL-2) with Electroporation

## Key facts

- **NCT ID:** NCT00223899
- **Lead sponsor:** Vical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-06
- **Final completion:** 2008-10
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00223899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00223899, "A Trial to Evaluate the Safety of Intratumoral VCL-IM01 Followed by Electroporation in Metastatic Melanoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00223899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*